Trillium Therapeutics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trillium Therapeutics

TRIL 20.69

-1.5%

Oct 30 12:52 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: tuck	4/30/2019 10:11:23 AM
	Read Replies (1) of 294

So Dr. Stiernholm is out, and Dr. Uger takes the helm for the moment. Share price movement this suggests investors don't see any imminent improvement. The corporate update regarding progress in the clinical continues to show how slow that progress is. Their mistakes in dosing apparently cost them a partnership, as well as the lead in the space. It will some time and some more dilution before they have much to show anyone. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next